|
[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Xie, D., Ren, Z., Zhou, J., Fan, J. and Gao, Q. (2020) 2019 Chinese Clinical Guidelines for the Management of Hepatocellular Carcinoma: Updates and Insights. Hepatobiliary Surgery and Nutrition, 9, 452-463. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Forner, A., Reig, M. and Bruix, J. (2018) Hepatocellular Carcinoma. The Lancet, 391, 1301-1314. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Harbeck, N., Rastogi, P., Martin, M., Tolaney, S.M., Shao, Z.M., Fasching, P.A., et al. (2021) Adjuvant Abemaciclib Combined with Endocrine Therapy for High-Risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis from the MonarchE Study. Annals of Oncology, 32, 1571-1581. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Li, Z., Li, F., Pan, C., He, Z., Pan, X., Zhu, Q., et al. (2021) Tumor Cell Proliferation (Ki-67) Expression and Its Prognostic Significance in Histological Subtypes of Lung Adenocarcinoma. Lung Cancer, 154, 69-75. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ramos-Santillan, V., Oshi, M., Nelson, E., Endo, I. and Takabe, K. (2024) High Ki67 Gene Expression Is Associated with Aggressive Phenotype in Hepatocellular Carcinoma. World Journal of Oncology, 15, 257-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhang, X., Wu, Z., Peng, Y., Li, D., Jiang, Y., Pan, F., et al. (2021) Correlationship between Ki67, VEGF, and P53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. BioMed Research International, 2021, Article ID: 6651397. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Nardone, V., Reginelli, A., Rubini, D., Gagliardi, F., Del Tufo, S., Belfiore, M.P., et al. (2024) Delta Radiomics: An Updated Systematic Review. La radiologia medica, 129, 1197-1214. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ye, Z., Jiang, H., Chen, J., Liu, X., Wei, Y., Xia, C., et al. (2019) Texture Analysis on Gadoxetic Acid Enhanced-MRI for Predicting Ki-67 Status in Hepatocellular Carcinoma: A Prospective Study. Chinese Journal of Cancer Research, 31, 806-817. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Fan, Y., Yu, Y., Wang, X., Hu, M. and Hu, C. (2021) Radiomic Analysis of Gd-EOB-DTPA-Enhanced MRI Predicts Ki-67 Expression in Hepatocellular Carcinoma. BMC Medical Imaging, 21, Article No. 100. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Cai, C., Wang, L., Tao, L., Zhu, H., Ren, Y., Li, D., et al. (2025) Imaging‐Based Prediction of Ki‐67 Expression in Hepatocellular Carcinoma: A Retrospective Study. Cancer Medicine, 14, e70562. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zhao, Y., Xie, S., Wang, J., Zhang, Y., Li, W., Ye, Z., et al. (2023) Added Value of CE-CT Radiomics to Predict High Ki-67 Expression in Hepatocellular Carcinoma. BMC Medical Imaging, 23, Article No. 138. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhou, L., Chen, Y., Li, Y., Wu, C., Xue, C. and Wang, X. (2024) Diagnostic Value of Radiomics in Predicting Ki-67 and Cytokeratin 19 Expression in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 13, Article 1323534. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhang, D., Zhang, X., Lu, W., Liao, J., Zhang, C., Tang, Q., et al. (2024) Predicting Ki-67 Expression in Hepatocellular Carcinoma: Nomogram Based on Clinical Factors and Contrast-Enhanced Ultrasound Radiomics Signatures. Abdominal Radiology, 49, 1419-1431. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Napel, S., Mu, W., Jardim‐Perassi, B.V., Aerts, H.J.W.L. and Gillies, R.J. (2018) Quantitative Imaging of Cancer in the Postgenomic Era: Radio(geno)mics, Deep Learning, and Habitats. Cancer, 124, 4633-4649. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Jardim-Perassi, B.V., Huang, S., Dominguez-Viqueira, W., Poleszczuk, J., Budzevich, M.M., Abdalah, M.A., et al. (2019) Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models. Cancer Research, 79, 3952-3964. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wang, C., Wu, F., Wang, F., Chong, H., Sun, H., Huang, P., et al. (2025) The Association between Tumor Radiomic Analysis and Peritumor Habitat‐Derived Radiomic Analysis on Gadoxetate Disodium‐Enhanced MRI with Microvascular Invasion in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging, 61, 1428-1439. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Tang, M., Zhou, Q., Huang, M., Sun, K., Wu, T., Li, X., et al. (2021) Nomogram Development and Validation to Predict Hepatocellular Carcinoma Tumor Behavior by Preoperative Gadoxetic Acid-Enhanced MRI. European Radiology, 31, 8615-8627. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Murakami, T., Sofue, K. and Hori, M. (2022) Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging. Magnetic Resonance in Medical Sciences, 21, 168-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yan, M., Zhang, X., Zhang, B., Geng, Z., Xie, C., Yang, W., et al. (2023) Deep Learning Nomogram Based on Gd-EOB-DTPA MRI for Predicting Early Recurrence in Hepatocellular Carcinoma after Hepatectomy. European Radiology, 33, 4949-4961. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Yang, F., Wan, Y., Xu, L., Wu, Y., Shen, X., Wang, J., et al. (2021) MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study. Frontiers in Oncology, 11, Article 672126. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wu, H., Han, X., Wang, Z., Mo, L., Liu, W., Guo, Y., et al. (2020) Prediction of the Ki-67 Marker Index in Hepatocellular Carcinoma Based on CT Radiomics Features. Physics in Medicine & Biology, 65, Article ID: 235048. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Dong, Y., Zuo, D., Qiu, Y., Cao, J., Wang, H. and Wang, W. (2022) Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures. Diagnostics, 12, Article 2175. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Qiu, G., Chen, J., Liao, W., Liu, Y., Wen, Z. and Zhao, Y. (2023) Gadoxetic Acid-Enhanced MRI Combined with T1 Mapping and Clinical Factors to Predict Ki-67 Expression of Hepatocellular Carcinoma. Frontiers in Oncology, 13, Article 1134646. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Liu, Z., Yang, S., Chen, X., Luo, C., Feng, J., Chen, H., et al. (2022) Nomogram Development and Validation to Predict Ki-67 Expression of Hepatocellular Carcinoma Derived from Gd-EOB-DTPA-Enhanced MRI Combined with T1 Mapping. Frontiers in Oncology, 12, Article 954445. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Li, H., Zhang, J., Liu, B., Zheng, Z. and Xu, Y. (2025) Histogram Analysis of Multiple Mathematical Diffusion-Weighted Imaging Models for Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Frontiers in Oncology, 15, Article 1531236. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Yan, Y., Lin, X.S., Ming, W.Z., Chuan, Z.Q., Hui, G., Juan, S.Y., et al. (2024) Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Academic Radiology, 31, 859-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhang, H.D., Li, X.M., Zhang, Y.H., et al. (2023) Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI. Journal of Clinical and Translational Hepatology, 11, 350-359.
|
|
[29]
|
Zhang, Y., Yang, C., Qian, X., Dai, Y. and Zeng, M. (2024) Evaluate the Microvascular Invasion of Hepatocellular Carcinoma (≤5 cm) and Recurrence Free Survival with Gadoxetate Disodium‐Enhanced MRI‐Based Habitat Imaging. Journal of Magnetic Resonance Imaging, 60, 1664-1675. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Zhang, Y., Chen, J., Yang, C., Dai, Y. and Zeng, M. (2024) Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Diffusion-Weighted Imaging-Based Habitat Imaging. European Radiology, 34, 3215-3225. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Chen, Y., Qin, X., Long, L., Zhang, L., Huang, Z., Jiang, Z., et al. (2020) Diagnostic Value of Gd‐EOB‐DTPA‐Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging, 51, 1755-1763. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Hu, X., Yang, Z., Liang, H., Ding, Y., Grimm, R., Fu, C., et al. (2017) Whole‐Tumor MRI Histogram Analyses of Hepatocellular Carcinoma: Correlations with Ki‐67 Labeling Index. Journal of Magnetic Resonance Imaging, 46, 383-392. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Li, Y., Chen, J., Weng, S., Sun, H., Yan, C., Xu, X., et al. (2019) Small Hepatocellular Carcinoma: Using MRI to Predict Histological Grade and Ki-67 Expression. Clinical Radiology, 74, 653.e1-653.e9. [Google Scholar] [CrossRef] [PubMed]
|